Clinical trials in the U.S and Serbia tested the effectiveness of EatEnjoy Glutalytic in reducing negative gluten-related symptoms.
The American trial, carried out at Kennesaw State University, Georgia, concluded that Glutalytic®, reduced many of the symptoms that are encountered upon the consumption of gluten.
A 2018 study carried out at Belgrade University’s teaching hospital, KBC Bezanijska Kosa, showed statistically significant reductions in stomach pain, flatulence, bowel discomfort, food cravings and energy loss. The blend of enzymes in EatEnjoy Glutalytic is uniquely designed to break down gluten proteins faster and more efficiently than existing solutions on the market.
.